A Phase I Study to Evaluate Safety, Tolerability and Pharmacokinetics of ONO-4053 in Healthy Volunteers

NCT01537172 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Adult Subjects

Interventions

DRUG: ONO-4053
DRUG: Placebo

Sponsor

Ono Pharmaceutical Co., Ltd.